SCHEMBL14001052

SCHEMBL14001052

CC(C)CC(=O)N1CCC(Oc2ncnc(Nc3cnc(Cl)cc3F)c2C#N)CC1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 17/20 0.48
EGFR P00533 2/20 0.39
CYP2C9 P11712 1/20 0.39
NAMPT P43490 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388489 0.88 GPR119 (0.62) GPR119CYP2C9
SCHEMBL3161178 0.84 GPR119 (0.49) GPR119CYP2C9
SCHEMBL1893829 0.74 GPR119 (0.66) GPR119CYP2C9
SCHEMBL386065 0.74 GPR119 (0.61) GPR119CYP2C9
SCHEMBL387819 0.73 GPR119 (0.65) GPR119CYP2C9
SCHEMBL386216 0.73 GPR119 (0.65) GPR119CYP2C9
SCHEMBL389922 0.73 GPR119 (0.62) GPR119CYP2C9
SCHEMBL388773 0.73 GPR119 (0.62) GPR119CYP2C9
SCHEMBL1894615 0.73 GPR119 (0.62) GPR119CYP2C9
SCHEMBL389010 0.72 GPR119 (0.79) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470699-B2 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2008-12-30 US disclosed
US-7470699-B2 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2008-12-30 US disclosed